Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Microbiol.

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1646639

Correction: Anti-MRSA Activities of Enterocins DD28 and DD93 and Evidences on Their Role in the Inhibition of Biofilm Formation

Provisionally accepted
Ahmed  K Al AtyaAhmed K Al Atya1Yanath  BelguesmiaYanath Belguesmia1*Gabrielle  ChataigneGabrielle Chataigne1Rozenn  RAVALLECRozenn RAVALLEC1Anne  VachéeAnne Vachée2Sabine  SzuneritsSabine Szunerits1Rabah  BoukherroubRabah Boukherroub1Djamel  DriderDjamel Drider1*
  • 1Universite de Lille, Lille, France
  • 2Hopital Victor Provo, Roubaix, France

The final, formatted version of the article will be published soon.

Correction on: Al Atya AK, Belguesmia Y, Chataigne G, Ravallec R, Vachée A, Szunerits S, Boukherroub R and Drider D (2016) Anti-MRSA Activities of Enterocins DD28 and DD93 and Evidences on Their Role in the Inhibition of Biofilm Formation. Front. Microbiol. 7:817. doi: 10.3389/fmicb.2016.00817. In the published article, there was an error in [Figure 4] as published. [A wrong figure appeared]. The corrected [Figure 4] and its caption **[ Biofilms formation by MRSA-S1 on AISI 304L stainless steel slides conditioned with antimicrobial agents for 2 h and then washed and inoculated with 2 ml of.10 7 CFU/ml MRSA-S1 culture before removing, washing and adding TSB-YE medium for 0, 3, 6 and 24 h of incubation at 37 °C. Concentrations of antimicrobial agents used were 8 mg/L for erythromycin, 0.03 mg/L for rifampin, 200 mg/L for enterocin DD28, 50 mg/L + 1 mg/L for enterocin DD28 + erythromycin, respectively. Biofilms were stained with the BacLight Live/Dead Viability Kit and imaged by epifluorescence microscopy after staining pattern for live cells (green) and dead cells (red). The experiments were performed at least twice and representative images are shown.] appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: Enterocins, antibiotics, MRSA, Synergism, Bacteriocins

Received: 13 Jun 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Al Atya, Belguesmia, Chataigne, RAVALLEC, Vachée, Szunerits, Boukherroub and Drider. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yanath Belguesmia, Universite de Lille, Lille, France
Djamel Drider, Universite de Lille, Lille, France

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.